Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Gamma for Secondary Infection Prevention in ICU
NCT06774235Phase 3Recruiting
- Sponsor
- CHU de Limoges
- Start
- Jul 2025
- Primary completion
- Oct 2028
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon gamma-1b in immunosuppression, sponsored by CHU de Limoges. Started Jul 2025; status: recruiting.
02
Drugs
interferon gamma-1b
03
Conditions
immunosuppression
Beyond the preview
Go deeper on NCT06774235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06774235.